RAFFA WEALTH MANAGEMENT, LLC’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
BTW
CIM
RP
CFM
LKIM
PFSRSONJ
JIC
RAFFA WEALTH MANAGEMENT, LLC's CRL Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Charles River Laboratories (CRL) stake by 33% in Q2 2026, buying an estimated $178 and bringing the position to 4 shares worth $907. The position accounts for ﹤0.01% of the portfolio, ranked #1047.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.8K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 4 shares of Charles River Laboratories worth $907 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 1 Charles River Laboratories share in Q2 2026, an estimated $178.
- Charles River Laboratories made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1047 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Charles River Laboratories position peaked at $8.8K in Q2 2025.
- 137 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.